Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre-disposition pending between fiction and reality

@inproceedings{Gressner2007BiomarkersOH,
  title={Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre-disposition pending between fiction and reality},
  author={OA Gressner and Ralf Weiskirchen and A. M. Gressner},
  booktitle={Journal of cellular and molecular medicine},
  year={2007}
}
Fibrosis is a frequent, life-threatening complication of most chronic liver diseases. Despite major achievements in the understanding of its pathogenesis, the translation of this knowledge into clinical practice is still limited. In particular, non-invasive and reliable (serum-) biomarkers indicating the activity of fibrogenesis are scarce. Class I biomarkers are defined as serum components having a direct relation to the mechanism of fibrogenesis, either as secreted matrix-related components… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 38 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 138 references

Epithelial-mesenchymal transition and its implications for fibrosis.

The Journal of clinical investigation • 2003
View 9 Excerpts
Highly Influenced

Bone morphogenetic protein 7 is elevated in patients with chronic liver disease and exerts fibrogenic effects on human hepatic stellate cells

F Tacke, E Gäbele, +10 authors B. Schnabl
Dig Dis Sci • 2007

Similar Papers

Loading similar papers…